Literature DB >> 11870118

Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability.

Oi Shan Tang1, B Y Miao, Sharon W H Lee, Pak Chung Ho.   

Abstract

BACKGROUND: A sublingual misoprostol-alone regimen was used in 50 women requesting medical abortion at up to 12 weeks gestation. The efficacy and acceptability of this regimen were studied.
METHODS: The women were given 600 microg misoprostol sublingually every 3 h for a maximum of 5 doses.
RESULTS: The overall complete abortion rate was 86% (95% confidence interval: 74-93). The mean number of doses of misoprostol required was 4.1 +/- 1.1. There was no significant change in haemoglobin concentration and the median duration of vaginal bleeding was 15 days (range: 7-56). Diarrhoea, fever and chills were the most common side-effects. The acceptability of this regimen of misoprostol was good: 97.7% of the women who had a complete abortion would choose this method again and 88.4% would recommend it to others. They preferred sublingual misoprostol as it is convenient to take, avoids the painful vaginal administration and gives more privacy during the abortion process.
CONCLUSION: This regimen of sublingual misoprostol is an effective and acceptable method of medical abortion. Randomized controlled trials are required to compare the efficacy of various misoprostol-alone regimens of medical abortion. Pharmacokinetic studies and clinical trials are needed to find out the most appropriate dose, dosing interval and route of administration of misoprostol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870118     DOI: 10.1093/humrep/17.3.654

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes.

Authors:  Deepika Nautiyal; Krishna Mukherjee; Inderjeet Perhar; Navnita Banerjee
Journal:  J Obstet Gynaecol India       Date:  2014-07-23

2.  Comparison of sublingual, vaginal, and oral misoprostol in cervical ripening for first trimester abortion.

Authors:  Shagufta Parveen; Zaffar Abbas Khateeb; S M Mufti; M A Shah; Vishal R Tandon; S Hakak; Z Singh; Shagufta Yasmeen; Shakeel A Mir; Rehana Tabasum; Nasreen Jan
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

3.  Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise.

Authors:  Devendra Singh Kushwah; Beenu Kushwah; Mohd Tariq Salman; V K Verma
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

4.  Comprehensive abortion care: evidence of improvements in hospital-level indicators in Tigray, Ethiopia.

Authors:  Ndola Prata; Suzanne Bell; Amanual Gessessew
Journal:  BMJ Open       Date:  2013-07-24       Impact factor: 2.692

5.  Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination.

Authors:  Helena von Hertzen; Gilda Piaggio; Lena Marions
Journal:  Reprod Health       Date:  2008-06-23       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.